MARKET INDEX
KOSPI5,036.67▼ 1.25%
KOSDAQ658.76▼ 1.04%
S&P 5007,416.59▼ 1.92%
NASDAQ24,509.76▼ 2.49%
USD/KRW1,339.45▲ 3.63 (+0.27%)
WTI Crude$85.07▼ 0.76%
BTC/USD$64,762▼ 0.10%
KOSPI5,036.67▼ 1.25%
KOSDAQ658.76▼ 1.04%
S&P 5007,416.59▼ 1.92%
NASDAQ24,509.76▼ 2.49%
USD/KRW1,339.45▲ 3.63 (+0.27%)
WTI Crude$85.07▼ 0.76%
BTC/USD$64,762▼ 0.10%
헤더 좌
헤더 우
BREAKING
MARKET Times 공식 배너

HLB Panagene Expands Global Molecular Diagnostics Reach at MEDICA 2026

HLB Panagene is showcasing its molecular diagnostic technologies at MEDICA 2026 in Germany, engaging with 12 international firms to expand its global distribution network.

HLB Panagene Expands Global Molecular Diagnostics Reach at MEDICA 2026
MTIMES Archive / Photo

Showcasing molecular diagnostic technologies and key products at the world's largest medical device exhibition.

Discussing supply partnerships with 12 companies across Europe, the Middle East, Latin America, and Asia to expand overseas sales channels.

HLB Panagene is participating in MEDICA 2026, the world's largest medical device exhibition held in Germany, to accelerate its international business expansion.

MEDICA 2026, which opened in Düsseldorf on the 16th and runs for four days until the 19th, brings together global companies and industry professionals across various sectors, including medical devices, in-vitro diagnostics, and digital healthcare, to showcase their latest technologies and products.

HLB Panagene has been a consistent participant at MEDICA since 2013, fostering relationships with international medical device and diagnostic industry stakeholders. This year, the company is operating an exhibition booth to present its molecular diagnostic technologies and core products, while actively discussing potential business collaborations with international buyers.

During the exhibition, the company plans to conduct business meetings with 12 firms from regions including Europe, the Middle East, Latin America, and Asia. These discussions aim to identify market demand by country, secure new clients, and explore concrete cooperation strategies to expand product supply.

Jang In-keun, CEO of HLB Panagene, stated, "MEDICA serves as a vital platform for identifying the latest trends in the global diagnostic market and discussing business opportunities directly with international partners. Through this exhibition, we will actively promote our molecular diagnostic technology and product competitiveness, further strengthening our position in the global market by expanding our overseas distribution networks and securing new accounts."

MARKET Times

MTIMES Global Editorial Statement

This analysis is provided for international business intelligence and informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. For inquiries regarding licensing or syndication, please contact [email protected].

← More in CorporateBack to Top ↑

Related Market & Corporate Intelligence

Samsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesSamsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessFed Warns of Hidden Risks in Big Tech AI Investment SurgeFed Warns of Hidden Risks in Big Tech AI Investment SurgeEuropean Equities See Largest Inflow in Five Years as Investor Focus Shifts from US TechEuropean Equities See Largest Inflow in Five Years as Investor Focus Shifts from US Tech
HomeTOP10AlmatenPicksCorpAlgiten